237 related articles for article (PubMed ID: 19626591)
1. How to evaluate emerging technologies in cervical cancer screening?
Arbyn M; Ronco G; Cuzick J; Wentzensen N; Castle PE
Int J Cancer; 2009 Dec; 125(11):2489-96. PubMed ID: 19626591
[TBL] [Abstract][Full Text] [Related]
2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
5. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial.
Ronco G; Cuzick J; Pierotti P; Cariaggi MP; Dalla Palma P; Naldoni C; Ghiringhello B; Giorgi-Rossi P; Minucci D; Parisio F; Pojer A; Schiboni ML; Sintoni C; Zorzi M; Segnan N; Confortini M
BMJ; 2007 Jul; 335(7609):28. PubMed ID: 17517761
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
8. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
Arbyn M; Sankaranarayanan R; Muwonge R; Keita N; Dolo A; Mbalawa CG; Nouhou H; Sakande B; Wesley R; Somanathan T; Sharma A; Shastri S; Basu P
Int J Cancer; 2008 Jul; 123(1):153-60. PubMed ID: 18404671
[TBL] [Abstract][Full Text] [Related]
10. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.
Whitlock EP; Vesco KK; Eder M; Lin JS; Senger CA; Burda BU
Ann Intern Med; 2011 Nov; 155(10):687-97, W214-5. PubMed ID: 22006930
[TBL] [Abstract][Full Text] [Related]
11. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.
Anttila A; Kotaniemi-Talonen L; Leinonen M; Hakama M; Laurila P; Tarkkanen J; Malila N; Nieminen P
BMJ; 2010 Apr; 340():c1804. PubMed ID: 20423964
[TBL] [Abstract][Full Text] [Related]
12. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Ronco G; Dillner J; Elfström KM; Tunesi S; Snijders PJ; Arbyn M; Kitchener H; Segnan N; Gilham C; Giorgi-Rossi P; Berkhof J; Peto J; Meijer CJ;
Lancet; 2014 Feb; 383(9916):524-32. PubMed ID: 24192252
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.
Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Ghiringhello B; Girlando S; Gillio-Tos A; De Marco L; Naldoni C; Pierotti P; Rizzolo R; Schincaglia P; Zorzi M; Zappa M; Segnan N; Cuzick J;
Lancet Oncol; 2010 Mar; 11(3):249-57. PubMed ID: 20089449
[TBL] [Abstract][Full Text] [Related]
15. HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.
Andersen B; Njor SH; Jensen AMS; Johansen T; Jeppesen U; Svanholm H
Int J Gynecol Cancer; 2020 Nov; 30(11):1678-1683. PubMed ID: 33037107
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.
Kitchener HC; Almonte M; Thomson C; Wheeler P; Sargent A; Stoykova B; Gilham C; Baysson H; Roberts C; Dowie R; Desai M; Mather J; Bailey A; Turner A; Moss S; Peto J
Lancet Oncol; 2009 Jul; 10(7):672-82. PubMed ID: 19540162
[TBL] [Abstract][Full Text] [Related]
18. Technologic advances for evaluation of cervical cytology: is newer better?
Hartmann KE; Nanda K; Hall S; Myers E
Obstet Gynecol Surv; 2001 Dec; 56(12):765-74. PubMed ID: 11753179
[TBL] [Abstract][Full Text] [Related]
19. Cell preparation methods and criteria for sample adequacy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
McGoogan E; Colgan TJ; Ramzy I; Cochand-Priollet B; Davey DD; Grohs HK; Gurley AM; Husain OA; Hutchinson ML; Knesel EA; Linder J; Mango LJ; Mitchell H; Peebles A; Reith A; Robinowitz M; Sauer T; Shida S; Solomon D; Topalidis T; Wilbur DC; Yamauchi K
Acta Cytol; 1998; 42(1):25-32. PubMed ID: 9479321
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]